Equities research analysts at Stifel Nicolaus initiated coverage on shares of Cooper Cos. (NYSE:COO) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a GBX 150 ($2.29) price target on the stock.
The analysts wrote, “We are initiating coverage of The Cooper Companies, Inc. (COO) with a Buy rating and $150 target price. We believe the risk profile of Cooper is lower than that of its high-growth peers. We point to the recurring nature of CooperVision’s (CVI) business (81% of total revenue) as well as our belief that revenue growth can be achieved from continued material and modality shift, and is not predicated on increases in contact lens prescriptions or pricing. For EPS growth, leverage in the business is likely to come from future revenue growth; however, substantial margin expansion can be achieved from reduced royalty payments alone, allowing for accelerating EPS growth in 2015.”
A number of other analysts have also recently weighed in on COO. Analysts at Ned Davis Research upgraded shares of Cooper Cos. from a “neutral” rating to a “buy” rating in a research note to investors on Monday, July 8th. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Cooper Cos. in a research note to investors on Thursday, June 27th. They now have a $130.00 price target on the stock, up previously from $125.00. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Cooper Cos. in a research note to investors on Wednesday, June 19th. They now have a $128.00 price target on the stock.
Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $126.57.
Shares of Cooper Cos. (NYSE:COO) traded down 0.16% during mid-day trading on Wednesday, hitting $129.94. Cooper Cos. has a one year low of $75.97 and a one year high of $130.69. The stock’s 50-day moving average is currently $124.0. The company has a market cap of $6.322 billion and a P/E ratio of 22.33.
Cooper Cos. (NYSE:COO) last posted its quarterly earnings results on Thursday, June 6th. The company reported $1.50 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.38 by $0.12. The company had revenue of $384.04 million for the quarter, compared to the consensus estimate of $389.14 million. During the same quarter in the prior year, the company posted $1.12 earnings per share. The company’s quarterly revenue was up 11.4% on a year-over-year basis. Analysts expect that Cooper Cos. will post $6.22 EPS for the current fiscal year.
The Cooper Companies, Inc (NYSE:COO) is a global medical products company that serves the specialty healthcare market through its two business units, CooperVision, Inc (CVI) and CooperSurgical, Inc (CSI).